Latest News

Biosign and ALQAEM introduce UFIT(R) at the Arab Health Congress in Dubai

TORONTO Jan. 24 United Arab Emirates January 24-27, 2011

Peter Tassiopoulos

UFIT(R) TEN-20 is Biosign’s online monitor for blood pressure and blood glucose. The device takes the pulse at the wrist through an inflatable cuff and immediately produces blood pressure and blood glucose measurement results. All measurements are non-invasive and passive. The results are stored on Biosign’s servers along with the test sample. The readings and the reports can be reviewed on a secure web portal and integrated into electronic medical records. The system has been assessed and certified as meeting the requirements of ISO 9001:2008, ISO 13485-2003, and Directive 93/42/EEC ("CE Mark").

John Rizvi

Middle East Middle East Middle East $80 billion

About Biosign Technologies Inc.

About ALQAEM International (FZE)

Sharjah, United Arab Emirates Dubai Abu Dhabi United Arab Emirates July 2010

Forward-Looking Statements

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Biosign Technologies Inc.

Leave a comment

seks shop - izolasyon
basic theory test book basic theory test